ATLAS / Macro Radar / Reporting / BFRI

Biofrontera Inc. (BFRI) reporting calendar

Biofrontera Inc. files periodic reports with the SEC as BFRI on Nasdaq. Atlas tracks 19 filed reports for this issuer, each linked to its original EDGAR accession.

Next window
27 Jul 2026 – 1 Sep 2026
Latest report
10-Q
Period ended
31 Mar 2026
Filed
14 May 2026
Reports on record
19

How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 45 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.

Open BFRI market profile Latest filing on SEC EDGAR ↗ Pharmaceutical Preparations reporting datesAll Nasdaq reporting dates

Filed periodic reports

FormPeriod endedFiledLagSEC accession
10-Q31 Mar 202614 May 202644 days0001493152-26-023119
10-K31 Dec 202519 Mar 202678 days0001493152-26-011625
10-Q30 Sep 202512 Nov 202543 days0001493152-25-021945
10-Q30 Jun 202513 Aug 202544 days0001641172-25-023486
10-Q31 Mar 202515 May 202545 days0001641172-25-011031
10-K31 Dec 202420 Mar 202579 days0001493152-25-011052
10-Q30 Sep 202414 Nov 202445 days0001493152-24-045220
10-Q30 Jun 202414 Aug 202445 days0001493152-24-032216
10-Q31 Mar 202415 May 202445 days0001493152-24-019878
10-K31 Dec 202315 Mar 202475 days0001493152-24-010133
10-Q30 Sep 20239 Nov 202340 days0001493152-23-040132
10-Q30 Jun 202311 Aug 202342 days0001493152-23-027701
10-Q31 Mar 202312 May 202342 days0001493152-23-016636
10-K31 Dec 202213 Mar 202372 days0001493152-23-007472
10-Q30 Sep 202214 Nov 202245 days0001493152-22-031682
10-Q30 Jun 202212 Aug 202243 days0001493152-22-022202
10-Q31 Mar 202213 May 202243 days0001493152-22-013163
10-K31 Dec 202111 Apr 2022101 days0001493152-22-009519
10-Q30 Sep 202130 Nov 202161 days0001493152-21-030058

Source: SEC EDGAR company submissions for CIK 0001858685. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.